Neflumozide
Neflumozide is a pharmaceutical compound that has been studied for its potential therapeutic effects. It is classified under the category of antineoplastic agents, which are drugs used to treat cancer by inhibiting the growth of malignant cells.
Mechanism of Action[edit | edit source]
Neflumozide works by interfering with the cell cycle of cancer cells, thereby preventing their proliferation. The exact molecular mechanism is still under investigation, but it is believed to target specific enzymes involved in cell division.
Clinical Trials[edit | edit source]
Several clinical trials have been conducted to evaluate the efficacy and safety of Neflumozide in treating various types of cancer, including breast cancer, lung cancer, and colorectal cancer. Preliminary results have shown promise, but further studies are needed to confirm its effectiveness and determine the optimal dosage.
Side Effects[edit | edit source]
Like many antineoplastic agents, Neflumozide can cause a range of side effects. Common side effects include nausea, vomiting, fatigue, and hair loss. More severe side effects may include neutropenia, anemia, and thrombocytopenia.
Pharmacokinetics[edit | edit source]
The pharmacokinetics of Neflumozide involve its absorption, distribution, metabolism, and excretion. It is typically administered intravenously, and its bioavailability is nearly 100%. The drug is metabolized primarily in the liver and excreted through the kidneys.
Related Compounds[edit | edit source]
Neflumozide is structurally related to other antineoplastic agents such as doxorubicin and paclitaxel. These compounds share similar mechanisms of action and are often used in combination therapies to enhance treatment efficacy.
Future Research[edit | edit source]
Ongoing research aims to better understand the molecular targets of Neflumozide and to develop more effective treatment protocols. Studies are also exploring its potential use in combination with other therapeutic agents to improve patient outcomes.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
-
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
